These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15126562)

  • 1. Application of the Cre/loxP system to enhance thyroid-targeted expression of sodium/iodide symporter.
    Lin X; Fischer AH; Ryu KY; Cho JY; Sferra TJ; Kloos RT; Mazzaferri EL; Jhiang SM
    J Clin Endocrinol Metab; 2004 May; 89(5):2344-50. PubMed ID: 15126562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of iodide uptake and efflux in various human thyroid cancer cells by expressing sodium iodide symporter gene via a recombinant adenovirus.
    Lee WW; Lee B; Kim SJ; Jin J; Moon DH; Lee H
    Oncol Rep; 2003; 10(4):845-9. PubMed ID: 12792733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
    Li W; Tan J; Wang P; Wu P
    Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
    Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery.
    Cho JY; Xing S; Liu X; Buckwalter TL; Hwa L; Sferra TJ; Chiu IM; Jhiang SM
    Gene Ther; 2000 May; 7(9):740-9. PubMed ID: 10822300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3',5'-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells.
    Taki K; Kogai T; Kanamoto Y; Hershman JM; Brent GA
    Mol Endocrinol; 2002 Oct; 16(10):2266-82. PubMed ID: 12351692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene.
    So Y; Lee YJ; Lee WW; Chung JK
    Oncol Rep; 2013 Apr; 29(4):1666-70. PubMed ID: 23404348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
    Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
    J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficacy of transcriptionally targeted suicide gene/prodrug therapy for thyroid carcinoma with the Cre-loxP system.
    Nagayama Y; Nishihara E; Iitaka M; Namba H; Yamashita S; Niwa M
    Cancer Res; 1999 Jul; 59(13):3049-52. PubMed ID: 10397242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
    Venkataraman GM; Yatin M; Marcinek R; Ain KB
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
    Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
    Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-specific Cre-mediated activation of the diphtheria toxin gene in pituitary tumor cells: potential for cytotoxic gene therapy.
    Lee EJ; Jameson JL
    Hum Gene Ther; 2002 Mar; 13(4):533-42. PubMed ID: 11874631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.
    Tan J; Li W; Wang P
    Chin J Cancer; 2011 Aug; 30(8):574-80. PubMed ID: 21801606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of human sodium-iodide symporter gene expression mediated by recombinant adenovirus in skeletal muscle of living rats.
    Yang HS; Lee H; Kim SJ; Lee WW; Yang YJ; Moon DH; Park SW
    Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1304-11. PubMed ID: 15221289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
    Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
    Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor.
    Li W; Venkataraman GM; Ain KB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1080-7. PubMed ID: 17164311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter.
    Gao XF; Zhou T; Chen GH; Xu CL; Ding YL; Sun YH
    Asian J Androl; 2014; 16(1):120-3. PubMed ID: 24369144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
    Kim KI; Kang JH; Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC
    J Nucl Med; 2007 Sep; 48(9):1553-61. PubMed ID: 17704247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.